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Introduction
Irritable Bowel Syndrome (IBS) and endometriosis are little 
researched co-morbidities. Symptoms overlap and the lack of 
a suitable biological marker or a non-invasive diagnostic test, 
in both cases, make diagnosis complex and confusing.1 IBS is a 
gastrointestinal condition diagnosed by the absence of organic 
disease and the presence of recurrent abdominal pain and alteration 
in bowel habit.2
Endometriosis is a gynaecological disease with chronic pelvic 
pain being an overriding symptom.3 Women with endometriosis 
suffer from severe gastro-intestinal symptoms which mirror those 
of IBS patients.3 Visceral hypersensitivity is a key feature in both 
conditions.1,4 A diet low in short-chain-fermentable carbohydrates 
(FODMAPs) has been shown to be a credible dietary treatment for 
IBS, specifically by reducing visceral hypersensitivity.5 It therefore 
makes sense to test the effect of the low FODMAP diet on patients 
with endometriosis. Moore et al.  recently published a retrospective 
analysis of the overlap between endometriosis and IBS.4 To our 
knowledge this is the first case report on the use of the low FODMAP 
diet in a patient with endometriosis and IBS.
IBS and Endometriosis
Endometriosis is a benign, gynaecological disease associated 
with symptoms of chronic pelvic pain, deep dyspareunia, severe 
dysmenorrhea, ovulation pain, and dyschezia.1 Between 15–22% of 
women with endometriosis are known to have IBS-like symptoms.6 
In a recent study, 36% of women diagnosed with IBS via the ROME 
III criteria (Table 1) had concurrent endometriosis.4 Histologically 
18% of women with endometriosis and gastrointestinal symptoms 
had bowel lesions.6 More than a third of women with endometriosis 
report worsening of gastrointestinal symptoms at the time of menses 
when compared with controls.6 Over 50% of women with IBS note 
their symptoms worsen with their cycle.6 
Table 1: Rome III Diagnostic Criteria* for IBS2 
Recurrent abdominal pain or discomfort† at least 3 days a month in the 
past 3 months, associated with two or more of the following:
• Improvement with defecation
• Onset associated with a change in frequency of stool
• Onset associated with a change in form (appearance) of stool
* Criteria fulfilled for the past 3 months with symptom onset of at least 6 months before diagnosis
† “Discomfort” means an uncomfortable sensation not described as pain
There is an overlap of symptoms between the two conditions which 
makes diagnosis difficult. Visceral hypersensitivity, bloating, altered 
bowel habit, pain on defecation, nausea and a reduced quality of 
life are common in both conditions.4 At the cellular level, mast cell 
involvement has been implicated in IBS and likewise have been 
shown to be elevated in endometrionic tissue.6
Diet as a treatment for IBS
The role of diet in the management of IBS has been repeatedly 
reviewed before.7-9 Key scientific bodies have reviewed the 
latest available data and have made recommendations for health 
professionals. The American College of Gastroenterology recently 
updated their guidelines in 2014.10 The UK based National Institute 
for Heath and Care Excellence (NICE) guidelines for IBS were first 
published in 2008, updated in 2015 and 2017.8 Finally the most 
recently published British Dietetic Association (BDA) Gastrointestinal 
Specialist Group  (GSG) Position Statement on Dietary Management 
of IBS was published in 2016.2 Most of these guidelines recommend 
lifestyle modification (relaxation, exercise, stress reduction) and 
healthy eating guidance as the first line advice. 
There is a growing body of research on the effects of individual 
fermentable short chain carbohydrates on the gastrointestinal 
tract.5 In the last 10 years, evidence has emerged for the restriction 
of a group of shortchain fermentable carbohydrates which have 
collectively become known as FODMAPs. This is an acronym 
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FODMAPs* enter the small bowel.
If undigested, due to an enzyme shortage (e.g lactase) or lack of suitable fructose transporter mechanisms .              
FODMAPs cause an osmotic shift in the ileum drawing excess fluid into bowel softening the stool.
Triggering visceral hypersensitivity and subsequent pain.
&        Undigested FODMAPs *reach the large bowel where they are fermented by luminal bacteria 
producing increased methane, hydrogen and carbon dioxide triggering luminal distension,  increased pain, 
wind and bloating. 
Additional cellular impact - Immune modulation – increased mast cell activation.
Figure 1: Mechanism of action of short- chain fermentable carbohydrates in the bowel(9)
* FODMAPs – Fermentable Oligosaccharides, Disaccharides, Monosaccharides and  Polyols
 x
developed by Monash University, the pioneers of this treatment, and 
stands for Fermentable Oligosaccharides (e.g. wheat, rye, onion, 
garlic), Disaccharides (e.g. milk), Monosaccharides (e.g. mango, 
honey) And Polyols (e.g. xylitol, plums). The common factor in these 
foods is the size and chain length of these carbohydrate molecules, 
as they all contain between 1 and 10 glucose molecules. This group 
of short-chain carbohydrates is susceptible to colonic fermentation 
by a number of possible mechanisms, which have been shown to 
exacerbate IBS symptoms.5
Mechanisms of action 
As shown in Figure 1 there are several mechanisms of action 
to explain how the malabsorption of FODMAPs contributes to 
gastrointestinal symptoms.5,9 
There is strong evidence to support three mechanisms of action:
1. Augmentation of small intestinal water
Unabsorbed fructose, polyols and lactose in the small bowel lead 
to an osmotic shift resulting in increased small intestinal water. 
The resulting luminal distension leads to functional GI symptoms.
2. Increased colonic fermentation
The availability of non-digested and/or non-absorbed short-chain 
carbohydrates for colonic fermentation leads to accumulation of 
colonic gas including hydrogen and methane. This is likely to lead 
to further luminal distension.
3. Immune modulation
Mast cells play a role in different aspects of gastro-intestinal 
physiology and pathophysiology, particularly in intestinal 
sensation, motility, secretion, permeability, inflammation 
and immune modulation.11 A high FODMAP diet results in an 
increase in luminal histamine which is associated with mast cell 
degranulation and a heightened immune response.12
Moore et al.4 have recently published a retrospective analysis of 
prospectively collected data from women attending an IBS clinic who 
were put on a four week low FODMAP diet. Seventy-two percent of 
those with concurrent endometriosis reported a greater than 50% 
improvement in bowel function compared to 49% of those with no 
known endometriosis (P=0.001).
Risks of the low FODMAP diet
Despite its clinical effectiveness the low FODMAP diet does 
present some risks which need to be considered by the health care 
practitioner. Following a strict low FODMAP elimination diet leads 
to a reduction in prebiotic content. This has been shown, in various 
studies, to reduce the gut microbiological content, specifically 
Bifidobacteria species.12-14 Bifidobacteria are associated with many 
health benefits such as maintenance of the intestinal mucosal barrier 
and modulation of the immune system.5 Low levels of Bifidobacteria 
have been associated with increased days of pain in both healthy 
individuals as well as those with IBS.5 There is much research still to 
be done in this area but questions exist whether the effect of the low 
FODMAP diet on the microbial community has a detrimental effect 
on colonic health and whether the mucosal barrier is negatively 
affected with possible immune involvement5,12 
Nutrient intake has also been measured on the low FODMAP diet. 
Studies are small and inconclusive and the only nutrient that seems 
really at risk is calcium.15 In a recently completed long term study 
where patients were followed up for 6 and 18 months following 
reintroduction of FODMAPs, without additional micronutrient 
supplementation, no noticeable nutritional shortfalls were reported. 
This is attributed time and again to the presence of a FODMAP 
trained dietitian in the research team and the key need for careful 
dietetic supervision of elimination diets.13
Case report
A 23-year-old female student (Ms. A) was referred to the practice 
for dietary assessment. She had been diagnosed with IBS by her 
gynaecologist whom she had been seeing for the past two years for 
Figure 1: Mechanism of action of short-chain fermentable carbohydrates in the bowel 9
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endometriosis. Her clinical assessment by the gynaecologist had 
eliminated other organic disease. Four months prior to her dietetic 
appointment, she had been admitted for a laparoscopy to remove the 
endometriosis from her ovaries. The surgery was uncomplicated and 
at the time of surgery, it was noted that her colon was compacted. 
Since the surgery she had continued to complain of lower abdominal 
pain and other gut symptoms which persist throughout the month 
but worsen during menses. At first consultation, she was on the 
following medications; an oral contraceptive, a general multivitamin 
and aloe vera capsules.
The patient is in her final year of teacher training school. She lives on 
campus and described herself as ‘A-type’ personality. She suffered 
from a measure of anxiety and stress mostly linked to her academic 
performance and health. She exercised once or twice a day. She 
relaxed with her friends, going to gym and sleeping.
Anthropometry
Her weight was 60 kg with a height of 1.68 m, her BMI was calculated 
as 21.3 kg/m2. Her weight was stable but she expressed a wish to 
lose weight and admitted to being very conscious of her weight.
Biochemistry 
Her recent full blood count taken a few months earlier was normal. 
She also had a negative tissue transglutaminase (tTG IgA) blood test 
indicating absence of coeliac disease. Although she had previously 
avoided wheat, she reported she had been consuming gluten for the past 
6 months prior to the test.
Clinical
On arrival at the dietetic clinic she was asked to complete a 10-point 
symptom evaluation form developed by the practice and the Bristol 
Stool Form Chart.17 She reported her symptom severity as follows; 
bloating, wind, flatulence, gurgling and constipation were all 8/10, 
lethargy and abdominal pain 7/10 nausea 6/10. She experienced no 
urgency, diarrhoea or reflux. Her bowel opened once every 2–3 days 
with a type 1 or type 2 stool as per the Bristol Stool Form Chart.17 She 
reported no history of atopy.
Dietary
The patient had a history of avoiding starchy carbohydrates after 
having trialed the High Fat Low Carbohydrate diet. She had visited 
a dietitian 18 months before for assistance with weight loss and at 
that time she was persuaded to include carbohydrates again in her 
diet. A detailed diet history was taken. Her overall diet was adequate 
nutritionally, but lacked planning. She was inclined to miss meals 
and eat on the go. She would often have a diet shake for breakfast 
or homemade granola containing seeds, nuts, cocoa and oats. 
A sandwich or salad for lunch and a cooked meal at night containing 
meat, chicken and lots of vegetables. She snacked on fruit, seeds, 
nuts and dried fruit. She drank 3-4 cups of caffeinated fluid and 
3000 ml of water a day. Her alcohol intake was in the form of whisky 
or beer but only when socialising, approximately once a week. She 
listed her trigger foods as dairy, cauliflower, broccoli, onions and high 
fat meals.
Medical Management
Ms. A took a regular broad-spectrum multivitamin, a probiotic 
(containing a prebiotic), an aloe vera supplement to relieve 
constipation and her contraceptive. The gynaecologist had 
prescribed an osmotic laxative to be taken as required. No specific 
dose was prescribed.
Nutritional Management
After clinical and dietary assessment, the dietetic practice follows 
a 3-step patient management process (see Figure 2). In line with 
international guidelines, patients must follow first line dietary 
therapy and lifestyle modification before embarking on second line 
dietary treatment of the Low FODMAP Diet or fibre modification.2,8  
Initial Consultation
Ms. A was advised and counselled to follow first line advice for 
IBS as per a combination of guidance from NICE (2015)8 and BDA 
(2016),2 e.g. regular mealtimes, reduction of fat intake, increased 
fluid intake and a healthy balanced diet including all the food groups. 
Ms. A was also given general lifestyle management guidance. She 
was requested to monitor her symptoms on ingestion of high foods. 
Figure 2: IBS Dietary Treatment Pathway2,5,8
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She was also asked to complete a detailed food and symptom diary 
and return it to the dietitian within 2 weeks. She was advised to stop 
consuming aloe vera capsules due to lack of evidence and given 
guidance on appropriate laxative usage to aid her constipation. 
Provided the first line advice did not offer sufficient symptom relief 
and due to many possible FODMAP triggers in her dietary recall, 
she was also provisionally added to the next Low FODMAP Group 
Programme run by the dietetic practice.
Follow Up
Two weeks later Ms. A submitted her diary, she had a more consistent 
eating pattern and her bowel function had improved. She was now 
opening her bowel every second day with a type 2 stool (Bristol 
Stool Form Chart).17 There was no change in her bloating and her 
abdominal pain had felt worse at times. The nausea had disappeared 
and her bowels were little more regular with the use of the laxative 
combined with the diet (type 3, once every 1–2 days). She had 
started to make positive lifestyle changes such as better relaxation 
strategies, less strenuous exercise and better meal planning. Ms. 
A reported consistent and reproducible symptoms after consuming 
meals with high lactose content and she felt safer to change to 
lactose free milk and yoghurt. The dietitian examined her food diary 
and identified presence of many high FODMAP foods e.g. apples, 
onions, wheat and garlic.  On further discussion Ms. A elected to join 
the Low FODMAP Group Programme offered by the practice. This 
was a 16-week elimination and re-challenge programme managed 
by the practice (2 individual and 2 group meetings throughout the 
16 weeks).
FODMAP Group Programme
Ms. A joined the initial 3-hour group training programme, where she 
received interactive group education to ensure she was able to follow 
the strict 6-week elimination programme correctly. This includes 
comprehensive information on implementing the low FODMAP diet 
into her present healthy eating habits, label and menu reading, 
recipe adaptation, shopping and much more. She was asked to stop 
the probiotic as it contained a prebiotic of fructo-oligosacharide, 
which is also a high FODMAP ingredient. She then began the 6-week 
strict FODMAP elimination programme. This included the elimination 
of lactose. 
At her 3-week individual follow up she reported the Low FODMAP 
diet was going well. She had managed the substitutes and felt that 
her symptoms were improving. Her bowel had slowed down a little 
again to once every 2–3 days. She still had abdominal pain but fewer 
incidents of pain. She found eating out difficult and asked for help 
with sauces to add flavour. The dietitians checked her dietary recall 
and made a few minor changes to ensure nutritional adequacy and 
helped her with ideas to increase her fibre, regarding eating out and 
sauce alternatives.
At week 6 she returned for the group re-challenge Session. The 
2-hour session instructs the patients how to navigate the difficult 
challenge phase and provides extra information such as how to 
supplement with probiotics following the challenges. Finally, they 
receive some psychosocial education and its role in managing their 
symptoms. Ms. A completed a further symptom evaluation and 
we were pleased to see she was much better. She recorded her 
symptoms as ‘none’ or three out of ten or less. Her bowel opened 
every second day with the addition of 1 tablespoon of linseeds every 
morning, she had not used the laxative for a few weeks.
Nutritional Outcome
Ms. A saw a substantial improvement in her gastrointestinal 
symptoms of bloating, abdominal pain, wind, gurgling, constipation 
and nausea after first line dietary therapy (see Figure 3). After 
following the Low FODMAP Diet her symptoms improved further.
Ms. A took 10 weeks to complete the FODMAP reintroduction process. 
During this time, a dietitian remained in email communication to 
assist her with her challenges. She returned for her final consultation. 
Her symptoms were very much under control, her bowel opening 
every 1–2 days with a type 3 stool.
Figure 2: Ms. A - Change in symptom severity throughout the dietary process
Symptoms on arrival          Symptoms after First Line (after 2 week later)           Symptoms post FODMAP elimination (6 weeks later)
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Ms. A did not pass the fructose, mannitol or fructan challenges (see 
Table 2). She did tolerate a small dose of the wheat fructan and the 
initial dose of the onion fructan group; however, she felt the garlic 
challenge was not tolerated at all. She received food lists including 
advice on portion sizes in line with these results. She received further 
information regarding the modified FODMAP diet going forward and 
how to test her FODMAP threshold. She was cautioned about the 
cumulative FODMAP effect and asked to take a 6-week course of a 
high dose, multistrain probiotic to restore her gut flora.
Table 2: FODMAP Challenge Results
FODMAP CHALLENGE RESULTS
FODMAP CHALLENGE TOLERATED DOSE
Fructose Minimal ½ Initial dose
Polyols – Sorbitol Yes Full dose
Polyols – Mannitol No None
Fructans – Wheat group Minimal ½ Initial dose 
Fructans – Onion group Minimal Initial dose
Fructan – Garlic group No None
Galacto-oligosaccharides Yes Full dose
Lactose Yes Full dose
A month later she continued to do well, her dietary recall was well 
balanced with sufficient FODMAP restriction to keep her symptoms 
under control. She still used the laxative occasionally but reported 
she always understood what had gone wrong to bring on the 
constipation. There had been an occasional recurrence of bloating 
and abdominal pain, but she explained she was now able to trace it 
back to a particular meal or ingredient. She also understood that diet 
was not the only trigger for her symptoms and was committed to 
making further lifestyle changes to reduce her stress levels further. 
Discussion
Gastrointestinal symptoms frequently occur in patients with 
endometriosis whether they have bowel involvement or not.17 
Heightened visceral sensitivity has been documented in both 
endometriosis and IBS.18,19 The low FODMAP diet has been shown 
to decrease luminal distension and reduce visceral irritation by 
decreasing excess fluid and gas in the gut.5,20
This case report demonstrates the efficacy of the low FODMAP 
dietary process in IBS and endometriosis. The interesting result 
in this particular case is the role of her preconceived ideas with 
respect to her food intolerances and the strength of the brain-gut 
involvement. The patient listed dairy as a trigger food at her initial 
visit, she felt she had failed the home lactose challenge test and 
therefore avoided dairy for the duration of the programme. When 
it came to challenging she managed to tolerate the double dose 
of milk with no symptoms.  This is often the case and indeed the 
dietary process involved in the low FODMAP programme allows the 
patient to discover their real triggers in a safe, controlled, and logical 
manner. It empowers the patients, to take control of their condition, 
they leave the programme fully understanding the effect of foods on 
their symptoms.
Conclusion
There is convincing evidence for the clinical efficacy of the low 
FODMAP diet in IBS.5 As confidence in the diet has grown amongst 
health care practitioners, there are exciting new applications. The 
overlapping pathophysiology of endometriosis and IBS make it a 
logical treatment solution. This case study demonstrates that the low 
FODMAP diet can be effective in reducing symptoms of patients who 
have endometriosis and IBS.
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